Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GEMP

Gemphire Therapeutics (GEMP) Stock Price, News & Analysis

Gemphire Therapeutics logo

About Gemphire Therapeutics Stock (NASDAQ:GEMP)

Advanced Chart

Key Stats

Today's Range
$0.63
$0.67
50-Day Range
$0.30
$6.38
52-Week Range
$0.24
$1.49
Volume
48,968 shs
Average Volume
127,174 shs
Market Capitalization
$9.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GEMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gemphire Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GEMP Stock News Headlines

Cold War Discovery Could Unlock $100 Trillion in Wealth
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
See More Headlines

GEMP Stock Analysis - Frequently Asked Questions

Gemphire Therapeutics Inc (NASDAQ:GEMP) posted its earnings results on Friday, March, 15th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.15.

Gemphire Therapeutics (GEMP) raised $30 million in an initial public offering on Friday, August 5th 2016. The company issued 3,000,000 shares at $10.00 per share. Jefferies and RBC Capital Markets served as the underwriters for the IPO and Canaccord Genuity and Roth Capital Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gemphire Therapeutics investors own include TG Therapeutics (TGTX), AcelRx Pharmaceuticals (ACRX), Pixelworks (PXLW), Clearside Biomedical (CLSD), Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX) and Melinta Therapeutics (MLNT).

Company Calendar

Last Earnings
3/15/2019
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GEMP
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.64 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
1.20

Miscellaneous

Free Float
N/A
Market Cap
$9.64 million
Optionable
Not Optionable
Beta
2.82
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:GEMP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners